20-31826725-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000375985.5(MYLK2):​c.1082+11G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0245 in 1,614,012 control chromosomes in the GnomAD database, including 608 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 42 hom., cov: 31)
Exomes 𝑓: 0.025 ( 566 hom. )

Consequence

MYLK2
ENST00000375985.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.02

Publications

2 publications found
Variant links:
Genes affected
MYLK2 (HGNC:16243): (myosin light chain kinase 2) This gene encodes a myosin light chain kinase, a calcium/calmodulin dependent enzyme, that is exclusively expressed in adult skeletal muscle. [provided by RefSeq, Jul 2008]
MYLK2 Gene-Disease associations (from GenCC):
  • hypertrophic cardiomyopathy 1
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 20-31826725-G-A is Benign according to our data. Variant chr20-31826725-G-A is described in ClinVar as Benign. ClinVar VariationId is 36649.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0192 (2923/152168) while in subpopulation NFE AF = 0.0278 (1890/67988). AF 95% confidence interval is 0.0268. There are 42 homozygotes in GnomAd4. There are 1432 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 2923 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000375985.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYLK2
NM_033118.4
MANE Select
c.1082+11G>A
intron
N/ANP_149109.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MYLK2
ENST00000375985.5
TSL:1 MANE Select
c.1082+11G>A
intron
N/AENSP00000365152.4
MYLK2
ENST00000375994.6
TSL:1
c.1082+11G>A
intron
N/AENSP00000365162.2
MYLK2
ENST00000468730.1
TSL:1
n.-52G>A
upstream_gene
N/A

Frequencies

GnomAD3 genomes
AF:
0.0192
AC:
2926
AN:
152050
Hom.:
42
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00483
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.0180
Gnomad ASJ
AF:
0.0361
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000416
Gnomad FIN
AF:
0.0367
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0278
Gnomad OTH
AF:
0.0168
GnomAD2 exomes
AF:
0.0203
AC:
5105
AN:
251324
AF XY:
0.0205
show subpopulations
Gnomad AFR exome
AF:
0.00499
Gnomad AMR exome
AF:
0.0113
Gnomad ASJ exome
AF:
0.0372
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0397
Gnomad NFE exome
AF:
0.0282
Gnomad OTH exome
AF:
0.0227
GnomAD4 exome
AF:
0.0250
AC:
36576
AN:
1461844
Hom.:
566
Cov.:
33
AF XY:
0.0244
AC XY:
17719
AN XY:
727216
show subpopulations
African (AFR)
AF:
0.00436
AC:
146
AN:
33480
American (AMR)
AF:
0.0125
AC:
559
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0347
AC:
907
AN:
26132
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00185
AC:
160
AN:
86254
European-Finnish (FIN)
AF:
0.0393
AC:
2099
AN:
53414
Middle Eastern (MID)
AF:
0.0113
AC:
65
AN:
5768
European-Non Finnish (NFE)
AF:
0.0281
AC:
31279
AN:
1111978
Other (OTH)
AF:
0.0225
AC:
1359
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
2443
4886
7330
9773
12216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1164
2328
3492
4656
5820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0192
AC:
2923
AN:
152168
Hom.:
42
Cov.:
31
AF XY:
0.0192
AC XY:
1432
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.00479
AC:
199
AN:
41512
American (AMR)
AF:
0.0179
AC:
274
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0361
AC:
125
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.000416
AC:
2
AN:
4806
European-Finnish (FIN)
AF:
0.0367
AC:
390
AN:
10614
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0278
AC:
1890
AN:
67988
Other (OTH)
AF:
0.0166
AC:
35
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
147
294
440
587
734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0220
Hom.:
14
Bravo
AF:
0.0178
Asia WGS
AF:
0.00202
AC:
8
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
2
not provided (2)
-
-
1
Cardiomyopathy (1)
-
-
1
Hypertrophic cardiomyopathy 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
10
DANN
Benign
0.51
PhyloP100
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76530988; hg19: chr20-30414528; API